Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
Michael W StewartCollege of Medicine, Mayo Clinic, Jacksonville, FL, USAAbstract: Age-related macular degeneration (AMD) has become a major public health problem and a leading cause of blindness in industrialized nations. AMD results from the ageing eye's inability to metabolize and disp...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-07-01
|
| Series: | Clinical Ophthalmology |
| Online Access: | http://www.dovepress.com/clinical-and-differential-utility-of-vegf-inhibitors-in-wet-age-relate-a10519 |